Advertisement

The Utility of CSF Xpert MTB/RIF in Diagnosis of Tubercular Meningitis in Children

  • Jyothy A.
  • Vinod H. RatageriEmail author
  • Shivanand Illalu
  • S. R. Fattepur
  • P. K. Wari
Original Article
  • 36 Downloads

Abstract

Objective

To determine the utility of CSF Xpert MTB/RIF (GeneXpert) in diagnosis of tubercular meningitis in children in the age group of 2 mo to 12 y.

Methods

This hospital based prospective observational study was conducted at Department of Pediatrics, Karnataka Institute of Medical Sciences (KIMS), Hubli from December 2015 through November 2016. All children with clinically suspected tuberculous meningitis (TBM) were included in the study. These children underwent a detailed history taking, clinical examination, blood investigations, lumbar puncture and CT brain. Cerebrospinal fluid (CSF) samples were sent for CSF GeneXpert examination. Statistical analysis was done using IBM SPSS Statistics Version 20.

Results

A total of 28 children were enrolled in the study. Six (21.4%), 4 (14.3%) and 18 (64.3%) cases were definite, probable and possible TBM cases respectively. Most common age group affected was <5 y (83.33%) with median age 2.5 y (IQR 4.875). Male:female ratio was 1.5:1. CSF GeneXpert was tested positive in 6 cases (21.4%). The sensitivity of the test against the clinical scoring (>/=10) was 46.15% (95% CI, 19.22–74.87) and specificity was 100% (95% CI, 78.20–100). There was a significant association between CSF GeneXpert and Mantoux test (P = 0.002), CSF cell type >50% lymphocytes (P = 0.005) and CSF protein >100 mg/dl (P = 0.025) along with CT hydrocephalus (P = 0.021), granuloma (P = 0.009) and basal exudates (P = 0.025). None of the cases were tested smear positive for acid-fast bacilli (AFB).

Conclusions

CSF GeneXpert is superior to smear for AFB in TBM.

Keywords

CSF Xpert MTB/RIF TBM Clinical score Children 

Notes

Acknowledgements

The authors thank the Director, Principal and Medical Superintendent, KIMS, Hubli.

Authors’ Contribution

JA: Designed the study, collected the materials and wrote the manuscript; VHR: Helped in designing the study, writing the manuscript; SRF and SI: Reviewed the literature and helped in managing the cases; PKW: Reviewed the literature and helped in manuscript writing. VHR is the guarantor for this article.

Compliance with Ethical Standards

Conflict of Interest

None.

References

  1. 1.
    WHO. WHO Global tuberculosis report 2016 [Internet]. 2016. Available at: http://www.who.int/tb/publications/global_report/en/. Accessed 14 Jan 2018.
  2. 2.
    RNTCP (DGHS), TB India 2016 by RNTCP Annual Report. Available at: https://www.tbcindia.gov.in/showfile.php?lid=3180. Accessed 10 Dec 2018.
  3. 3.
    Brancusi F, Farrar J, Heemskerk D. Tuberculous meningitis in adults: a review of a decade of developments focusing on prognostic factors for outcome. Future Microbiol. 2012;7:1101–16.CrossRefPubMedGoogle Scholar
  4. 4.
    Sarah JG, Martin AE. Tuberculosis and fungal and parasitic infections of cental nervous system. In: Albright AL, Pollack IF, Adelson PD, editors. Principles and Practice of Pediatric Neurosurgery, 2nd ed. New York: Thieme Medical Publishers; 2013. p. 1182–96.Google Scholar
  5. 5.
    Solomons RS, Visser DH, Friedrich SO, et al. Improved diagnosis of childhood tuberculous meningitis using more than one nucleic acid amplification test. Int J Tuberc Lung Dis. 2015;19:74–80.CrossRefPubMedGoogle Scholar
  6. 6.
    Boehme CC, Nicol MP, Nabeta P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet. 2011;377:1495–505.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children: policy update. World Health Organization (2013). Available at: http://www.who.int/iris/handle/10665/112472. Accessed 14 Jan 2019.
  8. 8.
    Murthy JMK. Tuberculous meningitis: the challenges. Neurol India. 2010;58:716–22.CrossRefPubMedGoogle Scholar
  9. 9.
    Marais S, Thwaites G, Schoeman JF, et al. Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis. 2010;10:803–12.CrossRefGoogle Scholar
  10. 10.
    Alvarez-Uria G, Azcona JM, Midde M, Naik PK, Reddy S, Reddy R. Rapid diagnosis of pulmonary and extrapulmonary tuberculosis in HIV-infected patients. Comparison of LED fluorescent microscopy and the GeneXpert MTB/RIF assay in a district hospital in India. Tuberc Res Treat. 2012;1–4.Article ID: 932862.Google Scholar
  11. 11.
    Nhu NTQ, Heemskerk D, Thu DDA, et al. Evaluation of GeneXpert MTB/RIF for diagnosis of tuberculous meningitis. J Clin Microbiol. 2014;52:226–33.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Bhatia R, Dayal R, Jindal S, Agarwal D, Goyal A. GeneXpert for diagnosis of tubercular meningitis. Indian J Pediatr. 2016;83:1353–5.CrossRefPubMedGoogle Scholar
  13. 13.
    Patel VB, Theron G, Lenders L, et al. Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous meningitis in a high burden setting: a prospective study. PLoS Med. 2013;10:e1001536.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Thwaites GE, Tran TH. Tuberculous meningitis: many questions, too few answers. Lancet Neurol. 2005;4:160–70.CrossRefPubMedGoogle Scholar
  15. 15.
    Patel VB, Singh R, Connolly C, et al. Cerebrospinal T-cell responses aid in the diagnosis of tuberculous meningitis in a human immunodeficiency virus- and tuberculosis-endemic population. Am J Respir Crit Care Med. 2010;182:569–77.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Van Well GTJ, Paes BF, Terwee CB, et al. Twenty years of pediatric tuberculous meningitis: a retrospective cohort study in the western cape of South Africa. Pediatrics. 2009;123:e1–8.CrossRefPubMedGoogle Scholar
  17. 17.
    Ozateş M, Kemaloglu S, Gürkan F, Ozkan U, Hoşoglu S, Simşek MM. CT of the brain in tuberculous meningitis. A review of 289 patients. Acta Radiol. 2000;41:13–7.CrossRefPubMedGoogle Scholar
  18. 18.
    Rock RB, Olin M, Baker CA, Molitor TW, Peterson PK. Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev. 2008;21:243–61.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Miftode EG, Dorneanu OS, Leca DA, et al. Tuberculous meningitis in children and adults: a 10-year retrospective comparative analysis. PLoS One. 2015;10:e0133477.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Yaramiş A, Gurkan F, Elevli M, et al. Central nervous system tuberculosis in children: a review of 214 cases. Pediatrics. 1998;102:E49.CrossRefPubMedGoogle Scholar
  21. 21.
    Israni A, Dave D, Mandal A, et al. Tubercular meningitis in children: clinical, pathological, and radiological profile and factors associated with mortality. J Neurosci Rural Pract. 2016;7:400–4.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Bang ND, Caws M, Truc TT, et al. Clinical presentations, diagnosis, mortality and prognostic markers of tuberculous meningitis in Vietnamese children: a prospective descriptive study. BMC Infect Dis. 2016;16:573.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Thwaites GE. Advances in the diagnosis and treatment of tuberculous meningitis. Curr Opin Neurol. 2013;26:295–300.CrossRefPubMedGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2019

Authors and Affiliations

  1. 1.Department of PediatricsKarnataka Institute of Medical SciencesHubliIndia

Personalised recommendations